China SXT Pharmaceuticals, Inc.

SXTC ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2018
Assets
Cash & Equivalents $657.8K
Accounts Receivable $2.6M
Inventory $1.3M
Total Current Assets $6.1M
Property, Plant & Equipment $862.5K
Goodwill —
Intangible Assets (Excl. Goodwill) $60.7K
Total Assets $7.7M
Liabilities
Accounts Payable $2.4M
Total Current Liabilities $4.4M
Long-Term Debt —
Total Liabilities $4.4M
Stockholders' Equity
Retained Earnings $1.5M
Total Stockholders' Equity $3.3M
← Newer Page 2 of 2 Older →